11 Earnings Previews Include AT&T and Yahoo!

NEW YORK (TheStreet) -- Today's pre-earnings buy-and-trade profiles cover 11 companies in seven sectors who report quarterly results after hours today or premarket tomorrow.

The most watched report comes from Yahoo! (YHOO) afterhours today with the stock below its 50-day simple moving average at $38.82 for the first time since July 8. Dow component AT&T  (T) also reports after hours today with the stock near a 52-week low at $33.09.

Boeing (BA) will be the focus premarket tomorrow with this stock the only Dow component that has a sell rating. Boeing set an all-time intra-day high at $144.57 on Wednesday then ended last week at $136.65 which is below the low of the prior week setting up what could be a key reversal given lower closes this week and next.

Amgen (AMGN) ($118.52): Analysts expect the company to earn $1.64 a share after hours today. Amgen represents the medical sector which is 37.8% overvalued with an underweight rating as 33.3% of the 762 stocks in the sector have sell or strong sell ratings according to www.ValuEngine.com. Amgen set an all-time intraday high at $124.46 on Wednesday then reversed direction ending last week above its 50-day simple moving average at $115.12 with the 200-day SMA at $109.55. The weekly chart is positive with the stock above its five-week modified moving average at $116.85 with rising stochastics and its 200-week SMA at $75.21. Amgen has a hold rating is 16% overvalued with a gain of 38.5% over the last 12 months. Monthly and semiannual value levels are $115.06 and $102.54 with a quarterly risky level at $125.26.

Boeing ($137.36): Analysts expect the company to earn $1.58 a share premarket tomorrow. Boeing represents the aerospace sector which is 33% overvalued with an underweight rating as 79.5% of the 73 stocks in the sector have sell or strong sell ratings. The stock ended Monday above its 50-day SMA at $136.62 with its 200-day SMA at $114.50. The weekly chart shifts to negative with a close this week below its five-week MMA at $136.61 with declining stochastics and its 200-week SMA at $80.23. Boeing has a sell rating is 28.3% overvalued with a gain of 85.6% over the last 12 months. My semiannual and quarterly value levels are $123.73, $117.06 and $120.52 with weekly and monthly risky levels at $140.39 and $145.41.

Cullen Frost Bank (CFR) ($73.54): Analysts expect the company to earn 97 cents a share on Wednesday. The regional bank is in the finance sector which is 21.3% overvalued with an equal-weight rating as 83% of the 2956 stocks in the sector have hold ratings. The stock traded to a 2014 high at $76.51 on Wednesday then declined to $73.18 on Monday above its 50-day and 200-day SMAs at $73.09 and $69.40. The weekly chart shifts to negative on a close this week below its five-week MMA at $73.44 with declining stochastics and its 200-week SMA at $58.61. Cullen Frost has a hold rating is 20.8% overvalued with a gain of 25.5% over the last 12 months. Annual value levels are $63.30 and $62.84 with semiannual and quarterly pivots at $70.62, $72.17 and $75.11 with a monthly risky at $80.93.

Cirrus Logic (CRUS) ($19.62): Analysts expect the company to earn 68 cents a share after hours today. Cirrus represents the computer and technology sector which is 35.4% overvalued with an overweight rating as 51.6% of the 1125 stocks in the sector have buy or strong buy ratings. The stock as been below its 200-day SMA at $20.49 since Nov. 11 and is below its 50-day SMA at $19.88. The weekly chart is negative with the stock below its five-week MMA and 200-week SMA at $20.02 and $21.22 with oversold stochastics. Cirrus has a buy rating is 11.5% overvalued with a loss of 32% over the last 12 months. My annual pivot is $18.84 with annual and monthly pivots at $20.72 and $21.47 and semiannual risky levels at $32.60 and $33.31.

Dow Chemical (DOW) ($43.10): Analysts expect the company to earn 43 cents a share premarket Wednesday. Dow Chemical represents the basic materials sector which is 11.7% overvalued with an underweight rating as 64.1% of the 387 stocks in the sector have sell or strong sell ratings. The stock traded to a 2014 high at $46.85 on Jan. 22 then declined to $42.54 on Monday above its 50-day and 200-day SMAs at $41.93 and $37.66. The weekly chart is neutral with the stock above five-week MMA and 200-week SMA at $42.48 and $32.62 with declining stochastics. Dow Chemical has a sell rating is 36.4% overvalued with a gain of 25.2% over the last 12 months. My semiannual value level is $40.69 with quarterly and monthly pivots at $42.05 and $42.71 and weekly and semiannual risky levels at $$46.59 and $48.45.

If you liked this article you might like

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

FDA Approves First 'Biosimilar' for Cancer Treatment

Amgen Builds on a Breakout

How I've Prepared for Hurricane Irma -- and a Market Pullback

How I'm Prepared for Irma -- and a Pullback